Insider selling showcases potential mistrust in Deciphera Ph...
Insider selling showcases potential mistrust in Deciphera Pharmaceuticals' stock. Despite some buying, the overall transactions need careful monitoring before investing.
President Of Deciphera Pharmaceuticals Sold 30% Of Their Shares
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment